Prof Hulett completed his doctoral studies in 1994 at The University of Melbourne in on immune cell receptors in inflammation and allergy. He was awarded an NHMRC Peter Doherty Postdoctoral Fellowship (1995-1998) to continue his work on immune receptors at the Austin Research Institute. Prof Hulett moved to the John Curtin School of Medical Research (JCSMR) at The Australian National University in 1999 where he cloned the heparan sulphate-degrading enzyme heparanase and described its important role in inflammatory disease and cancer. Following the awarding of a Viertel Senior Medical Research Fellowship in 2002, Prof Hulett established an independent laboratory at the JCSMR to study molecular aspects of immune and tumour cell migration. In 2008 Prof Hulett moved his research group to the Department of Biochemistry at La Trobe University. His current research interests include inflammation and the tumour microenvironment, as well as the mechanism of action and therapeutic application of host defense peptides. Prof Hulett’s research has a strong translational focus and he has collaborated with a number of biotechnology companies including Progen Industries Ltd and Hexima Ltd. He has published over 150 peer-reviewed papers that have attracted 10,000+ citations, as well being lead inventor on 6 patents, and his research has been recognized with a number of awards including the Howard Florey Medal and the inaugural ACT Tall Poppy Science Award. Prof Hulett is a passionate advocate for science and medical research having been a Past-president of the Australian Society of Medical Research (ASMR) (2008) and is a current member of the ASMR National Policy Advisory Committee (2009-). He has previously held the positions of Research Director (2015-2016) and Deputy Director (2017-2019) of the La Trobe Institute for Molecular Science at La Trobe University. Prof Hulett is the current Head of Department of Biochemistry and Chemistry at La Trobe University (2019-).